F-star Therapeutics, Inc. Share Price
Equities
FSTX
US30315R1077
Biotechnology & Medical Research
Managers | Title | Age | Since |
---|---|---|---|
Neil Brewis
CEO | Chief Executive Officer | 57 | 19/11/20 |
Lindsey Trickett
IRC | Investor Relations Contact | - | - |
Trish Hurley
LAW | General Counsel | - | - |
Members of the board | Title | Age | Since |
---|---|---|---|
Neil Brewis
CEO | Chief Executive Officer | 57 | 19/11/20 |
1st Jan change | Capi. | |
---|---|---|
-2.31% | 103B | |
+0.56% | 95.28B | |
+1.69% | 22.15B | |
-17.37% | 21.02B | |
-9.30% | 18.15B | |
-41.01% | 16.73B | |
-14.85% | 16.05B | |
+3.21% | 13.68B | |
+33.54% | 12.17B |